8 months ago
40
Millions of Americans with obesity could be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare or Medicaid.
This, according to a new rule the Biden administration proposed Tuesday morning.
The rule, which would give millions of people access to weekly injectables, is expected to cost taxpayers as much as US $35 billion over the next decade.
The costly proposal from the U.S. Department of Health and Human Services sets the stage for a potential showdown between the powerful pharmaceutical industry and Robert F. Kennedy Jr.
Kennedy, an outspoken opponent of the weight-loss drugs, is President-elect Donald Trump’s nominee to lead the agency.
He could try to block the measure.
English (US) ·